Levofree Teva (Levodropropizine)

Levodropropizine acts on peripheral sensory nerve endings in the respiratory mucosa, inhibiting the activation of cough receptors. By blocking the afferent signals that trigger the cough reflex, it diminishes the urge to cough while preserving normal airway clearance mechanisms.

The appropriate dose of Levofree Teva is determined by the prescribing healthcare professional based on the patient’s age, weight, and clinical condition. Patients should follow the prescriber’s instructions and the product label; no universal dosing regimen is provided here.

Safety of levodropropizine in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To request Levofree Teva, submit an enquiry on the product page at gnhindia.com with the desired quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Levofree contains levodropropizine, a peripheral antitussive, whereas many other cough medicines (e.g., codeine) act centrally on the brainstem. The peripheral mechanism reduces cough without the sedation or dependence potential associated with central agents, making it a suitable option for patients who need to avoid central nervous system effects.

Levofree should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures to maintain its stability and efficacy throughout its shelf life.

Levofree is taken orally as directed by the prescriber. The tablet or liquid is swallowed with water, typically after meals, unless otherwise instructed. Patients should not crush or chew extended‑release forms unless the label specifically permits it.

Serious adverse reactions are rare but may include allergic manifestations such as rash, swelling, or difficulty breathing, as well as hepatic dysfunction indicated by abnormal liver enzymes and severe neutropenia. Any signs of these conditions require immediate medical attention.

Levofree is contraindicated in individuals with known hypersensitivity to levodropropizine or any excipients in the formulation. Caution is also advised for patients with severe hepatic or renal impairment, and it should be avoided in pregnant or breastfeeding women unless clearly indicated by a healthcare professional.